About City of Hope

City of Hope is an independent research and treatment center for diabetes, cancer and other life-threatening diseases. Bringing together the best in bench-to bedside research, City of Hope’s Arthur Riggs Diabetes & Metabolism Research Institute (AR-DMRI) is one of the world’s most comprehensive diabetes research programs.

City of Hope has a long and impressive history of groundbreaking discoveries in the field of diabetes spanning more than five decades since Rachmiel Levine, M.D., who discovered the role of insulin in glucose transport, launched diabetes research at City of Hope in the 1970s. The Institute is named for Arthur D. Riggs, Ph.D., another pioneer in the field famous for his work on synthesizing the first man-made gene and using synthetic genes to produce human insulin, now the standard of care for people with diabetes worldwide. The AR-DMRI is headed by Debbie Thurmond, Ph.D., a renowned research scientist, professor and founding chair of the Department of Molecular & Cellular Endocrinology.

City of Hope is also home to seminal National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) programs, such as the Human Islet Research Network (HIRN) and the Integrated Islet Distribution Program (IIDP), that lead the field of diabetes in diabetes research and translational potential.

City of Hope is located in Los Angeles, California, with community clinics throughout Southern California. It recently acquired Cancer Treatment Centers of America, extending its national reach. One of only 53 NCI-designated comprehensive cancer centers in the nation, it has been ranked as one of "America's Best Hospitals" in cancer by U.S. News & World Report for over 15 years. Founded in 1913, City of Hope is a pioneer in the fields of immunotherapy and clinical islet cell transplantation for diabetes, bone marrow transplantation and numerous breakthrough cancer drugs, many based on technology developed at the institution.

City of Hope’s commitment to Diversity, Equity, and Inclusion

We believe diversity, equity and inclusion is key in serving our mission to provide compassionate patient care, drive innovative discovery, and advance vital education focused on eliminating cancer and diabetes in all our communities. Our commitment to Diversity, Equity and Inclusion ensures we bring the full range of skills, perspectives, cultural backgrounds, and experiences to our work -- and that our teams align with the people we serve to build trust and understanding. We are dedicated to fostering a community that embraces diversity - in ideas, backgrounds, and perspectives; this is reflected in our work and represented in our people.

Position Summary

A Postdoctoral Fellowship opportunity is immediately available for a highly motivated individual in the laboratory of Adolfo Garcia-Ocaña, Professor and Chair of the Department of Molecular and Cellular Endocrinology in the Arthur Riggs Diabetes and Metabolism Research Institute.

The candidate will directly work with genetically modified mice, human islets, and mouse models of diabetes to decipher the role of small molecules and signaling pathways in pancreatic beta cell regeneration, protection, and function for diabetes therapy. The candidate will work within a team of highly energized and collaborative research investigators that include research associates, staff scientists and research faculty. Highly productive and innovative research investigators are encouraged to apply.

Skills that are used in the lab include: 3D imaging, omics, phenotypic characterization of genetically modified mice, human islet transplant in mice, and the analysis of diabetic mouse models.

Basic education, experience and skills required for consideration:

· PhD or M.D. obtained in the last three years.

Additional Information:

As a condition of employment, City of Hope requires staff to comply with all state and federal vaccination mandates.

· For more information on Adolfo Garcia Ocaña and his lab please visit here https://www.cityofhope.org/adolfo-garcia-ocana